Potassium bicarbonate 25 MEQ Effervescent Oral Tablet — RxCUI 1088772
RxNorm drug concept · Semantic clinical drug
RxCUI 1088772
Semantic clinical drug · SCD
● Current RxNorm concept 5 FDA products
7 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1088772
Official namePotassium bicarbonate 25 MEQ Effervescent Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asK+ bicarbonate 25 MEQ Effervescent Oral Tablet; Pot bicarbonate 25 MEQ Effervescent Oral Tablet; potassium bicarbonate 978 MG Effervescent Oral Tablet
FDA products mapped5
Package NDCs mapped7
Reported Medicaid activity (SDUD)3,739 prescriptions · 24 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
🕸️ Concept Web — How Potassium bicarbonate 25 MEQ Effervescent Oral T... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Potassium bicarbonate 25 MEQ Effervescent Oral Tablet
RxCUI 1088772 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Potassium bicarbonate
34296IN
-
Potassium bicarbonate
-
Brand names 2
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Effer-K
216861BN -
Klor-Con/EF
217909BN
-
Effer-K
-
Dose forms 8
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Potassium bicarbonate Effervescent Oral Tablet
1536876SCDF -
Potassium bicarbonate Oral Product
1165122SCDG -
Potassium bicarbonate Effervescent Oral Tablet [Effer-K]
1537125SBDF -
Potassium bicarbonate Effervescent Oral Tablet [Klor-Con/EF]
1537081SBDF -
Effer-K Oral Product
1173218SBDG -
Klor-Con/EF Oral Product
1172127SBDG -
Effervescent Oral Tablet
1535727DF -
Oral Product
1151131DFG
-
Potassium bicarbonate Effervescent Oral Tablet
-
Clinical & branded drugs 5
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Potassium bicarbonate 25 MEQ
316535SCDC -
Potassium bicarbonate 25 MEQ Effervescent Oral Tablet [Effer-K]
1088774SBD -
Potassium bicarbonate 25 MEQ Effervescent Oral Tablet [Klor-Con/EF]
1537082SBD -
Potassium bicarbonate 25 MEQ [Effer-K]
1537127SBDC -
Potassium bicarbonate 25 MEQ [Klor-Con/EF]
1537080SBDC
-
Potassium bicarbonate 25 MEQ
Showing up to 8 concepts per family — 16 of 16 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Potassium bicarbonate 25 MEQ
SCDC · 316535 -
Potassium bicarbonate Effervescent Oral Tablet
SCDF · 1536876 -
Potassium bicarbonate Oral Product
SCDG · 1165122
Brand-Name Concepts
-
Potassium bicarbonate 25 MEQ Effervescent Oral Tablet [Effer-K]
SBD · 1088774 -
Potassium bicarbonate 25 MEQ Effervescent Oral Tablet [Klor-Con/EF]
SBD · 1537082 -
Potassium bicarbonate 25 MEQ [Effer-K]
SBDC · 1537127 -
Potassium bicarbonate 25 MEQ [Klor-Con/EF]
SBDC · 1537080 -
Potassium bicarbonate Effervescent Oral Tablet [Effer-K]
SBDF · 1537125 -
Potassium bicarbonate Effervescent Oral Tablet [Klor-Con/EF]
SBDF · 1537081 -
Effer-K Oral Product
SBDG · 1173218 -
Klor-Con/EF Oral Product
SBDG · 1172127 -
Effer-K
BN · 216861 -
Klor-Con/EF
BN · 217909
📦 FDA Products & Package NDCs
5 products · 7 package NDCs
7 package NDCs map to RxCUI 1088772 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00245-5326-01 | 100 POUCH in 1 CARTON (0245-5326-01) / 1 TABLET, EFFERVESCE... | KLOR-Con/EF | Upsher-Smith Laboratories, Inc. | 2019-06-21 |
| 00245-5326-30 | 30 POUCH in 1 CARTON (0245-5326-30) / 1 TABLET, EFFERVESCEN... | KLOR-Con/EF | Upsher-Smith Laboratories, Inc. | 2019-06-21 |
| 51801-0001-30 | 30 POUCH in 1 CARTON (51801-001-30) / 1 TABLET, EFFERVESCEN... | Effer-K Orange | Nomax Inc. | 2013-01-30 |
| 51801-0001-40 | 100 POUCH in 1 CARTON (51801-001-40) / 1 TABLET, EFFERVESCE... | Effer-K Orange | Nomax Inc. | 2013-01-30 |
| 51801-0005-30 | 30 POUCH in 1 CARTON (51801-005-30) / 1 TABLET, EFFERVESCEN... | Effer-K Lemon Citrus | Nomax Inc. | 2013-01-30 |
| 51801-0006-30 | 30 POUCH in 1 CARTON (51801-006-30) / 1 TABLET, EFFERVESCEN... | Effer-K Cherry Berry | Nomax Inc. | 2013-01-30 |
| 51801-0007-30 | 30 POUCH in 1 CARTON (51801-007-30) / 1 TABLET, EFFERVESCEN... | Effer-K Unflavored | Nomax Inc. | 2013-01-30 |
Observed labelers:
Nomax Inc. (5) ·
Upsher-Smith Laboratories, Inc. (2)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.